Clinical Engagement Program

The Cancer Institute NSW partners with people working in cancer care delivery to ensure data is presented accurately. 

Learn about the Clinical Engagement Program, see a calendar of upcoming events, and express interest  in co-designing system-wide indicators.

Clinical Engagement Program
 

More information

Did you know that indicators presented in Reporting for Better Cancer Outcomes (RBCO) reports have been designed with expert input?

 

Stakeholder input supports the effective use of health data to improve cancer outcomes. The Clinical Engagement team relies on expert advice and experience in cancer services to:

• Identify opportunities for improvement in each cancer stream
• Prioritise focus areas 
• Sense-check any data analyses
• Understand data in order to present meaningful insights (e.g. indicators in RBCO reports)

The Clinical Engagement Program provides a unique opportunity for stakeholders to:

• Contribute to the development of system-wide indicators 
• Determine criteria for the “specialist centres” listed on the Cancer Institute NSW and CanRefer websites
• Collaborate across a range of professional backgrounds, organisations and locations 


Since 2017, the Clinical Engagement Program has worked with over 500 stakeholders from NSW and the ACT. This includes representatives from:
• 16 LHDs and specialty networks • 6 academic and professional organisations
• 16 private hospitals • A mix of metropolitan, rural and regional services 

Engagement activities are open to all healthcare professionals working in NSW or the ACT, regardless of level or facility type. Backgrounds may include (but are not limited to):
• Cancer care specialists (e.g. surgeons, medical oncologists, radiation oncologists)
• General Practitioners • Care coordinators
• Nurses • Aboriginal Health Workers
• Pathologists • Project managers/officers 
• Allied Health Workers • Researchers/academics

In 2022, the Clinical Engagement Program will be trialling new engagement modes to complement Clinical Advisory Groups.
This may include 1:1 interviews, small focus groups and surveys.

Melanoma: ongoing consultations from 2021 

January February March
April 

May
Melanoma: targeted consultation with MIA

June
 
July
Lung: Pathways Report Consultations
August
Lung: Pathways Report Consultations
September
 
October November December